In our ICU cohort, serum KIM-1 predicted AKI and showed greater diagnostic discrimination than both iFGF23 and cFGF23, consistent with a prospective sepsis cohort in which KIM-1 showed a higher AUC than FGF23 [26]. This evidence concerns the gene HAVCR1 and acute kidney injury.